New theoretical model of the evolution of blazed gratings in the ion beam etching process
Yuan, Jie, Li, Xingyu, Guan, Lulu, Liu, Zhuang, Dong, Shuo, Yang, Yuxin, Xu, Kaidong, Zhuang, Shiwei
Published in Optical materials express (01.05.2023)
Published in Optical materials express (01.05.2023)
Get full text
Journal Article
Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of HDM-2 antagonist JNJ-26854165 in patients with advanced refractory solid tumors
Tabernero, J., Dirix, L., Schoffski, P., Cervantes, A., Capdevila, J., Baselga, J., van Beijsterveldt, L., Winkler, H., Kraljevic, S., Zhuang, S. H.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Impact of prior thalidomide (T) therapy on the efficacy of pegylated liposomal doxorubicin (PLD) and bortezomib (B) in relapsed/refractory multiple myeloma (RRMM)
Sonneveld, P., Hajek, R., Nagler, A., Spencer, A., Bladé, J., Robak, T., Zhuang, S. H., Harousseau, J. L., Fruchtman, S., Orlowski, R. Z.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone
Harousseau, J. L., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., Robak, T., Xiu, L., Zhuang, S. H., Orlowski, R. Z.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Evaluation of Minimal Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated with Daratumumab in Combination with Lenalidomide Plus Dexamethasone or Bortezomib Plus Dexamethasone
Avet-Loiseau, Hervé, Casneuf, Tineke, Chiu, Christopher, Laubach, Jacob P., Lee, Je-Jung, Moreau, Philippe, Plesner, Torben, Nahi, Hareth, Khokhar, Nushmia Z, Qi, Ming, Schecter, Jordan, Carlton, Victoria, Qin, Xiang, Liu, Kevin, Wu, Kaida, Zhuang, Sen H., Ahmadi, Tahamtan, Sasser, A. Kate, San-Miguel, Jesús
Published in BLOOD (02.12.2016)
Published in BLOOD (02.12.2016)
Get full text
Journal Article
Conference Proceeding
The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia
Hallek, Michael, Kay, Neil E, Osterborg, Anders, Chanan-Khan, Asher A, Mahler, Michelle, Salman, Mariya, Wan, Ying, Sun, Steven, Zhuang, Sen Hong, Howes, Angela
Published in Future oncology (London, England) (01.01.2015)
Published in Future oncology (London, England) (01.01.2015)
Get full text
Journal Article
A Phase I clinical trial of ixabepilone (BMS‐247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days
Zhuang, Sen H., Agrawal, Manish, Edgerly, Maureen, Bakke, Susan, Kotz, Herb, Thambi, Paul, Rutt, Ann, Balis, Frank M., Bates, Susan, Fojo, Tito
Published in Cancer (01.05.2005)
Published in Cancer (01.05.2005)
Get full text
Journal Article
A phase II clinical trial of BMS-247550 (ixabepilone), a microtubule-stabilizing agent in renal cell cancer
Zhuang, S. H., Menefee, M., Kotz, H., Agrawal, M., Poruchynsky, M., Hung, E., Zhan, Z., Linehan, W. M., Bates, S. E., Fojo, T.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase II clinical trial of BMS-247550 (ixabepilone), a microtubule-stabilizing agent in renal cell cancer
Zhuang, S. H., Menefee, M., Kotz, H., Agrawal, M., Poruchynsky, M., Hung, E., Zhan, Z., Linehan, W. M., Bates, S. E., Fojo, T.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article